CNCR

Fund Description
The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.
Fund Profile
Fund Name Loncar Cancer Immunotherapy ETF
Fund Exchange Ticker CNCR
Fund Sponsor Exchange Traded Concepts
Fund ISIN US26922A8264
Net Expense Ratio 0.79 %
Fund Inception Date 13 October 2015
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Loncar Cancer Immunotherapy Index
Index Provider Loncar Investments
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 16 July 2019
Asset Under Management 38.01 Million (USD)
1 Month Total Return 5.72 %
Year To Date Return 11.69 %
1 Year Total Return -15.81 %
3 Year Annualized Total Return -2.67 %
NAV 21.1156
Share Outstanding 1,800,000
Top 10 Holdings (16 July 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
XENCOR INC XNCR EQUI 0.0526000000
IOVANCE BIOTHERAPEUTICS INC IOVA EQUI 0.0490000000
FATE THERAPEUTICS INC FATE EQUI 0.0489000000
ZYMEWORKS INC ZYME EQUI 0.0448000000
ARGENX SE - ADR ARGX EQUI 0.0446000000
PRECISION BIOSCIENCES INC DTIL EQUI 0.0427000000
ZIOPHARM ONCOLOGY INC ZIOP EQUI 0.0421000000
CRISPR THERAPEUTICS AG CRSP EQUI 0.0419000000
BLUEBIRD BIO INC BLUE EQUI 0.0412000000
MORPHOSYS AG MOR EQUI 0.0403000000